Goldman Sachs’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,718
Closed -$59K 6055
2022
Q1
$59K Sell
13,718
-21,859
-61% -$94K ﹤0.01% 5435
2021
Q4
$165K Sell
35,577
-8,545
-19% -$39.6K ﹤0.01% 5067
2021
Q3
$176K Sell
44,122
-102,403
-70% -$408K ﹤0.01% 4909
2021
Q2
$627K Buy
146,525
+8,875
+6% +$38K ﹤0.01% 4312
2021
Q1
$583K Buy
137,650
+13,704
+11% +$58K ﹤0.01% 4257
2020
Q4
$481K Sell
123,946
-5,736
-4% -$22.3K ﹤0.01% 3845
2020
Q3
$522K Buy
129,682
+94,129
+265% +$379K ﹤0.01% 3648
2020
Q2
$151K Buy
35,553
+14,358
+68% +$61K ﹤0.01% 4078
2020
Q1
$89K Sell
21,195
-181,364
-90% -$762K ﹤0.01% 4188
2019
Q4
$796K Buy
202,559
+176,706
+684% +$694K ﹤0.01% 3435
2019
Q3
$228K Buy
25,853
+6,388
+33% +$56.3K ﹤0.01% 3872
2019
Q2
$180K Sell
19,465
-24,540
-56% -$227K ﹤0.01% 3908
2019
Q1
$283K Sell
44,005
-22,015
-33% -$142K ﹤0.01% 3764
2018
Q4
$623K Buy
66,020
+8,416
+15% +$79.4K ﹤0.01% 3333
2018
Q3
$1.16M Buy
57,604
+18,820
+49% +$379K ﹤0.01% 3117
2018
Q2
$1.13M Buy
38,784
+29,356
+311% +$856K ﹤0.01% 3143
2018
Q1
$281K Sell
9,428
-18,246
-66% -$544K ﹤0.01% 3726
2017
Q4
$891K Buy
27,674
+5,147
+23% +$166K ﹤0.01% 3201
2017
Q3
$783K Buy
22,527
+7,226
+47% +$251K ﹤0.01% 3340
2017
Q2
$456K Sell
15,301
-9,181
-38% -$274K ﹤0.01% 3575
2017
Q1
$731K Buy
+24,482
New +$731K ﹤0.01% 3290
2016
Q2
Sell
-15,743
Closed -$329K 4844
2016
Q1
$329K Buy
15,743
+4,885
+45% +$102K ﹤0.01% 3484
2015
Q4
$293K Buy
10,858
+3,981
+58% +$107K ﹤0.01% 3523
2015
Q3
$191K Buy
+6,877
New +$191K ﹤0.01% 3896
2015
Q2
Sell
-16,052
Closed -$294K 4934
2015
Q1
$294K Buy
+16,052
New +$294K ﹤0.01% 3661